⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1262446 | 0.82 | SLC22A6 (0.50) | — | |
| SCHEMBL6734706 | 0.79 | SLC22A6 (0.47) | — | |
| SCHEMBL7518985 | 0.74 | — | — | |
| SCHEMBL7520601 | 0.74 | — | — | |
| SCHEMBL495774 | 0.74 | — | — | |
| SCHEMBL7525449 | 0.74 | — | — | |
| SCHEMBL7519154 | 0.74 | — | — | |
| SCHEMBL7521331 | 0.74 | — | — | |
| SCHEMBL28946387 | 0.72 | — | — | |
| SCHEMBL6460666 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021062048-A2 | METHODS AND SYSTEMS FOR MODULATING HEPATIC GABA PRODUCTION OR RELEASE TO ALTER FOOD INTAKE IN MONOGASTRIC SPECIES | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-04-01 | — | — | WO | claimed |
| US-20160193166-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-07-07 | — | — | US | claimed |
| US-9308260-B2 | Anticonvulsive pharmaceutical compositions | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2016-04-12 | — | — | US | claimed |
| EP-2421523-A1 | METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2012-02-29 | — | — | EP | claimed |
| US-20110070218-A1 | METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2011-03-24 | — | — | US | claimed |
| WO-2010121969-A1 | METHOD OF TREATING OR PREVENTING A CONVULSIVE DISORDER IN A PATIENT IN NEED THEREOF | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2010-10-28 | — | — | WO | claimed |
| US-20100184707-A1 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2010-07-22 | — | — | US | claimed |
| EP-2167068-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | Inserm-Institut National De La Sante Et De La Recherche Medicale (FR) | 2010-03-31 | — | — | EP | claimed |
| WO-2009144699-A1 | METHODS OF TREATING CANCER OF THE CENTRAL NERVOUS SYSTEM | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2009-12-03 | — | — | WO | claimed |
| WO-2009004082-A2 | ANTICONVULSIVE PHARMACEUTICAL COMPOSITIONS | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2009-01-08 | — | — | WO | claimed |
| EP-2011491-A1 | Anticonvulsive pharmaceutical compositions | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2009-01-07 | — | — | EP | claimed |
| EP-2007206-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMINE LEVELS | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 2008-12-31 | — | — | EP | claimed |
| WO-2007105203-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2007-09-20 | — | — | WO | claimed |
| US-20060024284-A1 | Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2006-02-02 | — | — | US | claimed |
| EP-1524989-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) | 2005-04-27 | — | — | EP | claimed |
| WO-2004012762-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-02-12 | — | — | WO | claimed |
| US-20230128194-A1 | METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2023-04-27 | — | — | US | disclosed |
| WO-2021203033-A2 | METHODS AND COMPOSITIONS TO ALTER HEPATIC GABA RELEASE TO TREAT OBESITY-RELATED CONDITIONS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2021-10-07 | — | — | WO | disclosed |
| EP-1524989-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT Co. LTD. (IL) | 2005-04-27 | — | — | EP | disclosed |
| WO-2004012762-A2 | METHOD AND COMPOSITION FOR PROTECTING NEURONAL TISSUE FROM DAMAGE INDUCED BY ELEVATED GLUTAMATE LEVELS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2004-02-12 | — | — | WO | disclosed |